open access publication

Article, 2017

Circular RNA expression is abundant and correlated to aggressiveness in early-stage bladder cancer

NPJ GENOMIC MEDICINE, ISSN 2056-7944, 2056-7944, Volume 2, 10.1038/s41525-017-0038-z

Contributors

Okholm, T. L. H. 0000-0002-2779-4029 (Corresponding author) [1] Nielsen, Morten 0000-0002-8972-7577 [1] Hamilton, Mark [2] Christensen, Lise Lotte [1] Vang, Soren 0000-0002-1899-4205 [1] Hedegaard, Jakob [1] Hansen, Thomas 0000-0002-7573-9657 [1] Kjems, Jorgen 0000-0003-4128-9317 [1] Dyrskjot, Lars 0000-0001-7061-9851 [1] Pedersen, Jakob S 0000-0002-7236-4001 (Corresponding author) [1]

Affiliations

  1. [1] Aarhus Univ Hosp, Dept Mol Med MOMA, DK-8200 Aarhus, Denmark
  2. [NORA names: AU Aarhus University; University; Denmark; Europe, EU; Nordic; OECD];
  3. [2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
  4. [NORA names: United States; America, North; OECD]

Abstract

The functions and biomarker potential of circular RNAs (circRNAs) in various cancer types are a rising field of study, as emerging evidence relates circRNAs to tumorigenesis. Here, we profiled the expression of circRNAs in 457 tumors from patients with non-muscle-invasive bladder cancer (NMIBC). We show that a set of highly expressed circRNAs have conserved core splice sites, are associated with Alu repeats, and enriched with Synonymous Constraint Elements as well as microRNA target sites. We identified 113 abundant circRNAs that are differentially expressed between high and low-risk tumor subtypes. Analysis of progression-free survival revealed 13 circRNAs, among them circHIPK3 and circCDYL, where expression correlated with progression independently of the linear transcript and the host gene. In summary, our results demonstrate that abundant circRNAs possess multiple biological features, distinguishing them from low-expressed circRNAs and non-circularized exons, and suggest that circRNAs might serve as a new class of prognostic biomarkers in NMIBC.

Data Provider: Clarivate